The major source of damage in arthritis is inflammation, which triggers a cascade of enzyme activity, immune cell attacks, and tissue breakdown that destroys cartilage, bone, or both. The specific damage mechanism differs depending on the type of arthritis, but in every form, the body’s own biological processes do more harm than any outside force. Understanding how each type causes damage helps explain why joints deteriorate and what can slow that process down.
How Osteoarthritis Destroys Cartilage
In osteoarthritis, the most common form of the disease, the primary damage happens to articular cartilage, the smooth, rubbery tissue that cushions the ends of bones inside a joint. This cartilage is made up of a protein framework (mostly type II collagen) filled with a gel-like substance called aggrecan that absorbs shock. The damage comes from enzymes that chew through both of these components.
One group of enzymes breaks down the collagen scaffold. The most important of these specifically targets type II collagen, the structural backbone of cartilage. A second group of enzymes attacks aggrecan, stripping away the cartilage’s ability to absorb compressive forces. Once both the scaffold and the cushioning material are degraded, cartilage thins, cracks, and eventually wears away entirely. On an X-ray, this shows up as joint space narrowing, the visible gap between bones shrinking as cartilage disappears.
What makes this damage so difficult to reverse is that the cells responsible for maintaining cartilage, called chondrocytes, start dying off as the process continues. Abnormal mechanical stress on cartilage can directly cause chondrocyte death. When cartilage is damaged by excessive loading or poor repair, the remaining chondrocytes undergo programmed cell death, which accelerates the breakdown already underway. Vigorous repetitive loading on normal cartilage can strip away protective molecules, denature collagen, and push chondrocytes toward self-destruction. It becomes a vicious cycle: damaged cartilage puts more stress on surviving cells, which die, leaving even less capacity for repair.
How Rheumatoid Arthritis Erodes Bone and Cartilage
Rheumatoid arthritis causes damage through a fundamentally different mechanism. It’s an autoimmune disease, and the destruction starts with the synovium, the thin membrane lining the inside of each joint. The immune system attacks this membrane, causing it to swell and thicken into a dense, aggressive tissue called the pannus. This inflammatory tissue doesn’t just sit there. It actively invades the surfaces where it contacts bone and cartilage.
Bone erosion in rheumatoid arthritis is carried out by specialized cells called osteoclasts, the only cells in the body capable of dissolving bone. Osteoclast precursor cells accumulate inside the pannus, right at the boundary between the inflamed tissue and the bone surface. Once activated, these cells latch onto bone, seal off a small pocket against the surface, and pump acid into it to dissolve the calcium. They also release enzymes that break down the bone’s protein matrix. The result is pits and craters in the bone that are visible on imaging and, over time, can compromise the joint’s structural integrity entirely.
Cartilage damage in rheumatoid arthritis happens through different pathways than the bone erosion, but both are driven by the same underlying inflammation. Inflammatory signaling molecules produced by immune cells play a central role. Some of these molecules directly reduce the survival and growth rate of cartilage cells, while also triggering the production of destructive enzymes similar to those seen in osteoarthritis. Others promote the production of nitric oxide inside cartilage cells, a chemical signal that pushes them toward death. The combination of direct immune attack on cartilage and enzyme-driven degradation means rheumatoid arthritis damages joints from multiple directions simultaneously.
How Quickly Does the Damage Happen?
In rheumatoid arthritis, the timeline from first symptoms to visible joint erosion can be surprisingly short. Research tracking patients from their earliest joint complaints to a formal diagnosis found a median gap of just 17 weeks. During that window, inflammation of the joint lining and swelling within the bone itself increased significantly. Bone erosions hadn’t yet appeared on imaging in that brief period, but the inflammatory changes already present are known precursors to erosion. This is why early treatment matters so much: the inflammatory machinery that causes permanent damage is already ramping up well before erosions become visible.
Crystal-Driven Damage in Gout
Gout causes joint damage through an entirely different trigger: crystals. When uric acid levels in the blood rise too high, needle-shaped crystals of monosodium urate form inside joints. These crystals activate a specific alarm system inside immune cells called the NLRP3 inflammasome, which unleashes a powerful inflammatory molecule (IL-1β). That molecule recruits waves of additional immune cells, primarily neutrophils, into the joint. The result is a self-feeding cycle of inflammation: more immune cells arrive, release more inflammatory signals, and draw in still more cells.
The acute attacks of gout are intensely painful because of this rapid immune escalation. Over time, repeated flares and persistent crystal deposits cause chronic inflammation that erodes cartilage and bone in much the same way that rheumatoid arthritis does. The crystals themselves also act as a physical irritant, embedding in joint tissue and provoking ongoing damage even between obvious flares.
Psoriatic Arthritis: Erosion and Abnormal Bone Growth
Psoriatic arthritis stands out because it causes two types of structural damage that seem contradictory: bone erosion and abnormal new bone formation. The inflammation in psoriatic arthritis often starts at the entheses, the points where tendons and ligaments attach to bone. This enthesitis triggers both the destruction of existing bone and the growth of new, disorganized bone at and around those attachment sites.
The abnormal bone growths, called enthesophytes, form at tendon insertion points and can also appear along the shafts of finger and toe bones. Dactylitis, the dramatic sausage-like swelling of an entire finger or toe, can involve both erosion and pathologic new bone formation happening at the same time. Research in animal models has shown that a specific inflammatory pathway involving IL-23 activates specialized immune cells at the entheses, which then produce a cocktail of inflammatory molecules that simultaneously promote bone resorption and trigger new, poorly organized bone to form in the wrong places.
The Common Thread Across All Types
Despite the different triggers, every major form of arthritis shares the same fundamental source of damage: the body’s own inflammatory and immune responses turning against joint tissue. In osteoarthritis, low-grade inflammation and mechanical stress activate enzymes that digest cartilage from within. In rheumatoid arthritis, an autoimmune attack recruits bone-dissolving cells directly to the joint surface. In gout, crystals hijack the immune system’s emergency response. In psoriatic arthritis, misplaced inflammation at tendon attachments drives both destruction and chaotic rebuilding.
The practical takeaway is that in every type of arthritis, controlling inflammation is the most important factor in preventing or slowing joint damage. The specific tools differ depending on the type, but the principle is the same. Cartilage and bone lost to arthritis don’t regenerate well on their own, which makes early recognition and management of the inflammatory process critical to preserving joint function over the long term.